St. Louis, MO, United States of America

Edwin Chen

This inventor holds 3 USPTO granted patents. Top assignees: Case Western Reserve University, University of South Florida, Washington University. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edwin Chen. Retrieved from https://idiyas.com/inventor/edwin-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Edwin Chen: Innovator in Synthetic Antigens

Introduction

Edwin Chen is a notable inventor based in St. Louis, MO (US), recognized for his contributions to the field of synthetic antigens. With a total of 3 patents, he has made significant strides in developing innovative solutions for treating and preventing diseases.

Latest Patents

Among his latest patents is the development of synthetic plasmodium antigens, compositions, and their uses. These patents provide synthetic antigens, antibodies, and pharmaceutical formulations, including vaccines. The methods outlined in these patents focus on treating and preventing infections and diseases through the administration of these synthetic antigens and related formulations.

Career Highlights

Edwin Chen has worked with prestigious institutions such as Washington University and Case Western Reserve University. His work in these organizations has contributed to advancements in medical research and innovation.

Collaborations

Edwin has collaborated with several professionals in his field, including Miriam Thankam George and Nichole Diane Salinas. These collaborations have further enhanced his research and development efforts.

Conclusion

Edwin Chen's work in synthetic antigens showcases his commitment to innovation in the medical field. His patents and collaborations reflect his dedication to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…